Yang and co-workers further showed in another study that a lower CD82 protein expression was associated with breast malignancy as analyzed by immunohistochemistry in breast tissues from 81 patients (comprising 7 normal tissues, 7 ductal carcinoma in situ and 67 breast cancer tissues) [40]. Here, CD82 is linked to breast cancer.